Navigation Links
ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
Date:10/17/2011

very technologies to the design of small molecule C5aR antagonists and selected CCX168 based on its potency, selectivity and favorable pharmacokinetics. CCX168 is one of four drug candidates discovered and developed by ChemoCentryx under the Company's alliance with GlaxoSmithKline (GSK) to identify molecules targeting four specific chemokine and chemoattractant receptors.  

About ANCA-Associated Vasculitis

Granulomatous polyangiitis and microscopic polyangiitis vasculitides are associated with anti-neutrophil cytoplasmic antibodies (ANCA). These auto-antibodies lead to the activation and increased adhesiveness of neutrophils to endothelial cells that line the blood vessels. These accumulating adhering neutrophils initiate an inflammatory cascade in the small blood vessels by secreting pro-inflammatory cytokines and chemoattractants.

If left untreated, AAV may lead to renal and pulmonary failure and is often fatal. AAV is currently treated with pulses of cyclophosphamide and high-dose systemic corticosteroids. Little advance in the treatment of these diseases has been made since the 1970's when these treatments were first introduced. Cyclophosphamide is a toxic alkylating agent. Systemic corticosteroid use is associated with increased risk of infection, osteoporosis, etc. Rituximab, azathioprine, methotrexate, or mycophenolate mofetil therapy are also used, but these drugs are associated with an increased risk of infection, bone marrow suppression, certain types of cancer, serious and sometimes fatal infusion reactions and progressive multifocal leukoencephalopathy (rituximab). Therefore, there is clearly still a substantial unmet medical need in treatment of patients with AAV.

About ChemoCentryx

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
2. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
3. PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryxs Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
4. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
5. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
6. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
7. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
8. ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohns Disease at the Digestive Disease Week (DDW) 2010 Conference
9. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
10. ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Treating Patients with Crohns Disease at the United European Gastroenterology Federation (UEGW) Meeting
11. ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015 Young Innovations ("Young"), ... equipment, today announced the acquisition of the professional ... Inc. ("MPL PDCMD"). MPL PDCMD manufactures fluoride varnish, ... and restorative dental procedures. "This ... business in attractive, high-growth segments," said Dave ...
(Date:8/4/2015)... 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) ... Sangamo,s executive vice president, research and development, will provide ... ® development programs and an overview of the ... 11, 2015, at the 2015 Wedbush Pacgrow Healthcare Conference. ... York, NY . The presentation will ...
(Date:8/4/2015)... -- HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... Executive Officer, Doug Godshall , is scheduled to ... at 8:30 a.m. EDT on Thursday, August 13, 2015.  ... the InterContinental Boston. A live webcast of ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2
... Alarmist Messages Reflect Group,s Anti-Meat Bias, Stand,in Sharp ... Sense, WASHINGTON, Oct. 31 The American ... Fund,s (WCRF),recommendations to limit red and processed meat ... bias and should be met with,skepticism because they ...
... Oct. 30 Although Spanish-speaking cancer,patients are rapidly ... Internet, there are very few Spanish-language Web sites,available ... presented,October 28, 2007, at the American Society for ... Angeles. Spanish-speaking cancer patients were also shown ...
Cached Medicine Technology:American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 2American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 3American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 4Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce 2
(Date:8/4/2015)... ... 2015 , ... Rhode Island Medical Imaging (RIMI) is pleased to announce the ... Wake Robin Road in Lincoln, RI. This satellite office will provide x-ray and ... out-patient x-ray hours in the state, which includes evenings and weekends. , “This ...
(Date:8/4/2015)... California (PRWEB) , ... August 04, 2015 , ... ... slides to Los Angeles commercial customers. Finding reliable hardware can be difficult ... liabilities. When putting an office together or designing a new facility, it ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... States, Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August ... save lives," Dr. Carmona said. "I strongly believe in the mission of the ...
(Date:8/4/2015)... ... 04, 2015 , ... Recent studies in the ... in binge drinking among certain populations and specific locations. Researchers, who ... examine trends and evidence to help facilitate health care treatment to meet current ...
(Date:8/4/2015)... ... August 04, 2015 , ... 24/7 Care At ... Angeles, Riverside, and San Bernardino, today announced that the U.S. Department of Veteran’s Affairs ... 24/7 Care At Home’s agency is well on the path to meeting the aspirational ...
Breaking Medicine News(10 mins):Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3
... Practice DirectorWESTFIELD, Ind., Feb. 10 maxIT Healthcare ... new division to provide technical and functional professional ... Healthcare, a leading professional services company for healthcare ... a presence in the health insurance market to ...
... de foie gras is discussed by Michael Greger of The ... forthcoming issue of the International Journal of Food Safety, ... as amyloid fibrils associated with damage to brain cells in ... can be present in the meat of poultry and mammals. ...
... launch a new national research centre to further understanding ... Centre, which will be opened by Sir William Stewart, ... 12 in the country to be funded by the ... the Government,s health research strategy. The joint venture has ...
... CHARLOTTE, N.C., Feb. 10 USHIFU, a worldwide ... invasive high intensity focused,ultrasound technologies, is pleased to ... consulting position of Chief Medical Officer. Dr.,Schoenberg is ... Urologic,Oncology who has authored more than 100 peer-reviewed ...
... 10 Erdman, A Cogdell Spencer,Company is pleased ... has earned the U.S. Environmental Protection Agency,s (EPA,s),prestigious ... efficiency,and environmental protection. America,s commercial buildings and industrial,plants ... similar facilities for energy,efficiency may qualify for the ...
... NUVA ), a medical device company focused ... the spine, announced today that Kevin O,Boyle, Executive Vice ... at the ROTH 21st Annual OC Growth Stock Conference ... Tuesday, February 17, 2009, at 11:30 a.m. PT.A live ...
Cached Medicine News:Health News:maxIT Healthcare Launches Healthcare Payer Professional Services Unit 2Health News:Give the foie gras a miss 2Health News:Biomedical research center opens in Liverpool 2Health News:USHIFU Appoints Mark Schoenberg, M.D. Chief Medical Officer 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 2Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 3Health News:Erdman, A Cogdell Spencer Company Earns the ENERGY STAR(R) for Superior Energy 4Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 2Health News:NuVasive to Present at ROTH 21st Annual OC Growth Stock Conference 3
A simple solution to hand assisted laparoscopic surgery....
... The HandPort Systems non-adhesive ... during Hand-Assisted Laparoscopic Surgrery (HALS) ... touch, grasp, and palpate throughout. ... small as 6 cm, patients ...
... 200 series offers a range of ... The design delivers therapy to meet ... promote results in commercial and clinical ... differentiator in the SleepStyle 200 series ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
Medicine Products: